US3629521A - Hearing systems - Google Patents

Hearing systems Download PDF

Info

Publication number
US3629521A
US3629521A US1334A US3629521DA US3629521A US 3629521 A US3629521 A US 3629521A US 1334 A US1334 A US 1334A US 3629521D A US3629521D A US 3629521DA US 3629521 A US3629521 A US 3629521A
Authority
US
United States
Prior art keywords
signal
transdermal
head
hearing
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US1334A
Inventor
Henry K Puharich
Joseph L Lawrence
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biolectron Inc
Intelectron Corp
Original Assignee
Intelectron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intelectron Corp filed Critical Intelectron Corp
Application granted granted Critical
Publication of US3629521A publication Critical patent/US3629521A/en
Assigned to BIOLECTRON, INC., 200 HOLT ST., HACKENSACK, NJ 07601 A DE CORP. reassignment BIOLECTRON, INC., 200 HOLT ST., HACKENSACK, NJ 07601 A DE CORP. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: CHEN, C.Y.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F11/00Methods or devices for treatment of the ears or hearing sense; Non-electric hearing aids; Methods or devices for enabling ear patients to achieve auditory perception through physiological senses other than hearing sense; Protective devices for the ears, carried on the body or in the hand
    • A61F11/04Methods or devices for enabling ear patients to achieve auditory perception through physiological senses other than hearing sense, e.g. through the touch sense

Definitions

  • Vastly improved and enhanced hearing may be achieved by imparting an AF acoustic signal to the ear system by means of conventional" transducers, such as electroacoustic speakers of in the ear" hearing aids; piezoelectric or mechanical transducers of conventional bone conduction"-type hearing aids; and so-called intraoral bone conduction transducers" of the type employed in the hearing system disclosed in Puharich and Lawrence US. Pat. No. 2,995,633 and No. 3,170,993 and No. 3,156,787, and by simultaneously applying a transdermal signal, which signal is an RF carrier signal amplitude modulated with AF information across the head of the subject, the head acting as capacitance in LC series resonance of the RF carrier frequency.
  • conventional transducers such as electroacoustic speakers of in the ear" hearing aids
  • piezoelectric or mechanical transducers of conventional bone conduction"-type hearing aids and so-called intraoral bone conduction transducers” of the type employed in the hearing system disclosed in
  • the applied balanced transdermal signal is in the form of a substantially pure sine wave, and it is applied to the head through one bare and one insulated electrode.
  • the applied transdermal signal is applied to the periaural and stylomastoid regions of the head and, accordingly, the apparatus of the invention may be readily adapted for use in the temples of yes fh nsa ddsvi s BALANCED OUTPUT AFC TD SYSTEM PATENlfiunzcz! zen I 31629521 SHEET 1 BF 2 BALANCED OUTPUT AFC TD SYSTEM INVENTORS HENRY K. PUHARICH JOSEPH 1.. LAWRENCE ATTORNEYS PATENTEU HECZI I971 $629,521
  • a conventional air-conducted acoustical signal may be delivered to the ear canal through an earphone type of speaker while a separate bone-conducted acoustic signal is delivered to the same normal channels of hearing, i.e., ear system or conventional hearing biomechanism, through an appropriately situated bone conductor.
  • ear system i.e., ear system or conventional hearing biomechanism
  • the present invention is directed to a specific improvement in the latter type of dual stimulation hearing systems and provides a significant improvement in hearing and speech discrimination over what has heretofore been obtainable in the art.
  • the vastly improved results of the method and apparatus of the new invention are obtained by the employment of a new and improved transdermal transmitting system; the employment of new and improved transdermal transducer means for. coupling the transdermal signal to the subject; and the employment of specific circuit parameters to achieve maximum improvement in hearing.
  • the apparatus of the present invention delivers an acoustic signal to an earphone or bone conductor type transducer and simultaneously delivers a transdermal signal to the head of the user at contralateral, periaural, and/or stylomastoid regions of the head.
  • the applied transdermal signal is a narrow width, amplitude modulated carrier signal, which carrier is usually in the range of 18 to 36 kHz. and which carrier is generated and coupled to the head of the subject in a manner whereby the transdermal signal is constantly driven across the head at peak LC series resonance of the carrier frequency.
  • Appropriate circuitry is provided in order to maintain the transdermally applied signal at the peak LC series resonance despite changes in the capacitance of the coupling of the transdermal signal to the head of the subject which may be occasioned by physiological changes in the subject.
  • improved speech discrimination is achieved by applying the transdermal signal to the head in the form of a substantially pure sine wave.
  • applied sine waves have tended to be distorted by the head.
  • the signal is applied to the stylomastoid regions of the head through one bare transdermal electrode and one insulated transdermal electrode placed contralaterally of the head, distortion of the sine wave is effectively eliminated.
  • FIG. 1 is a schematic view of a dual stimulus hearing system
  • FIG. 2 is an enlarged, cross-sectional view of an improved transdermal electrode means for use in coupling transdermal signals to a subject for the practice of the present invention
  • FIG. 3 is a preferred circuit arrangement for transdermal signal generating apparatus of the present invention.
  • transdermal signal generator 10 of the type disclosed in copending applications Ser. No. 633,035, now U.S. Pat. No. 3,563,246; Ser. No. 682,152; now U.S. Pat. No. 3,497,637; and Ser. No. 446,267, now abandoned.
  • the output of signal generator 10 is applied both acousticallyand transdermally to the head H of a subject 4 in the following manner and in accordance with the principles of the present invention.
  • the transdermal (TD) signal an amplitude modulated balanced RF signal
  • TD transdermal
  • the transdermal (TD) signal is coupled to the contralateral stylomastoid regions of the head through two separate inductors l2 and 13, a dielectric covered electrode 14, and a bare metal electrode 15, which electrodes are mounted on the inner surfaces of eyeglass temples T, as shown in FIG. 1. That is to say, the TD signal levels are balanced on each side of the head for optimum speech discrimination in accordance with the invention.
  • the dielectric covered electrode 14, which is shown in greater detail in FIG. 2 and described more specifically hereinafter, is placed on the same side of the head as the magnetic speaker 25 or other conventional transducer such as a bone conductor, which imparts an amplified acoustic signal directly into the ear system of the subject.
  • the bare electrode 15 is always placed on the opposite side of the head from the speaker 25 and the dielectric covered electrode 14, in accordance with a specific aspect of the present invention and in order to minimize distortion of the pure sine wave type of transdermal signal applied to the head. As shown in FIG. 1, electrodes 14 and 15 are connected to the output of the TD transmitter 10 by conductors l5 and 14, respectively.
  • the transdermal (TD) signal generator 10 may advantageously incorporate certain of the features described in a copending application, Ser. No. 633,035, filed Apr. 24, 1967, now U.S. Pat. No. 3,563,246, by Henry K. Puharich and Joseph L. Lawrence and also certain features described in an earlier application, Ser. No. 446,267, filed Apr. 6, 1965, now abandoned, by the same inventors. Reference to these applications may be made for further details.
  • the output of the transdermal signal generator 10 includes the pair of electrodes 14, 15, one of which is covered with a dielectric material (14) and the other of which is bare (15), although in certain applications (e.g. for totally deaf persons) both may be bare.
  • the electrodes 14, 15 are large inductances 12, 13, advantageously in the range of 2 to 30 millihenries and adjustable within that range for the accommodation of different subjects.
  • the TD signal generating circuitry of the transmitter 10 once energized and periodically pulsed, will oscillate at a frequency, herein referred to as the carrier frequency, which is substantially in a circuit resonant relation with the body of the subject, for maximum effectiveness of the power input, as described in more detail in the above-mentioned copending applications.
  • inductances l2, 13 are selected, with respect to a given sub ject, to provide a carrier signal at a frequency on the order of about 18 to about 36 kHz.
  • the resonant frequency may be kept constant notwithstanding momentary changes in circuit capacitance due to physiological and other changes in the body of the subject.
  • an in-phase acoustic or AF signal is simultaneously applied to the head of the subject through a conventional transducer such as an electromagnetic speaker of an earphone 25.
  • the acoustic signal is derived from the transdermal transmitter 10 and is applied to the coil 18 of the magnetic speaker 25 by connecting one side of the coil 18 to the conductor 14' by conductor 18', while the other side of the coil 18 is connected to a conductor 19' which is connected to an auxiliary bare metal electrode 19, which is placed against the side of the head (above the ear) opposite the site of the bare transdermal electrode 15.
  • two separate circuits will be completed through the head, a transdermal circuit between the electrodes 14 and and the acoustic circuit in which one side of the coil 18 is connected directly to the TD transmitter while the other side of the coil 18 is connected through the head to the other side of the TD transmitter 10.
  • a desired audio input in the form of an audio (AF) signal may be delivered to the transdermal transmitter system 10 through an input microphone 11 and the RF output of the transmitter will then be transmitted to the head of the subject applied thereto in the form of synchronous transdermal (RF) signals and acoustic (AF) signals, the combined effect of which, on hearing, will be significantly better than if either type of signal stimulation had been used independently.
  • AF audio
  • RF synchronous transdermal
  • AF acoustic
  • the subject's hearing and speech discrimination abilities typically will be enhanced (over completely unaided hearing) approximately 50 percent; the same may be said for the use of a transdermal type hearing aid by itself.
  • hearing abilities and speech discrimination have been enhanced (over completely unaided hearing) as much as 75 percent. Therefore, there is a definite increase in hearing (in terms of PB speech discrimination) over and beyond what has heretofore been available by the use of either pure acoustic stimulation or pure transdermal stimulation, which is attributed to synergistic effects of the combination of AF and RF signals in the manner described.
  • a sample group comprised of 12 hard of hearing patients was measured in a first or control testing" with standard audiometry techniques, and it was found that the average speech discrimination ability of the group was 26.2 percent as measured with phonetically balanced words, or the PB test.” This measurement represented a control" or standard for comparison. Thereafter, the 12 patients took several weeks of TD therapy in accordance with the principles and inventions set forth in detail in our copending application, Ser. No. 633,035, filed Apr. 24, 1967, for Electrotherapy System.” When measured in a second testing" with the same type of acoustic earphone PB test as used in establishing the control level, the average PB speech discrimination score of the group showed 43.0 percent or an increment of 16.8 percent.
  • the group of patients was tested in a third or TD testing with the TD signal rather than the acoustic signal, as the speech signal source, and the average PB speech discrimination of the group was 54 percent, an increment of 27.8 percent.
  • the group was tested with the signal source of the invention which combined the earphone signals of the second testing and the TD signal of the third tesu'ng, which signals were synchronously applied in accordance with the invention.
  • the average PB speech discrimination score of the group was raised to 73.8 percent, an improvement of 47.6 percent.
  • the dielectric covered electrode 14 may have the following configuration which has been found to couple, in a highly efficient manner, transdermal signals to the head of the subject.
  • the electrode 14 comprises three layers, a fine wire mesh conductor 52; a 0.25 mil Mylar film 54 superimposed on the mesh; and a heat bonded laminate 56 of 0.25 mil Mylarl-mil aluminum foil-0.25 mil Mylar superimposed on the layer 54.
  • the layers 52, 54, 56 loosely contact one another but are substantially unbonded throughout their interfaces.
  • the integrity of the electrode 14 may be preserved mechanically by uniting the peripheral portions of the layers with cement or using a plastic housing disc 58 to hold the layers in the aforementioned contacting, but unbonded, relation.
  • the disc electrode 14 may be used to advantage in any transdermal system such as those transdermal hearing and therapeutic systems illustrated and described in the aforementioned copending applications and may be formed as an integral part of an eyeglass hearing aid.
  • the unbonded laminar construction provides highly effecu've transdermal energy transfer (i.e., more power and less distortion) from a signal source to the nervous system.
  • the wire mesh conductor layers of the electrodes tend to maximize the nonuniform distribution of energy of the TD signal, while the loose or floating intermediate Mylar film layers tend to provide infinite capacitive adjustments as the layer flaps freely relative to the conductor.
  • the laminated layer which contacts the skin of the subject tends to smooth out nonuniforrnities of energy concentration which exist in the other two layers. That is to say, the foil conducts laterally of the direction of energy transfer, thus counteracting and preventing undue energy concentrations at the skin-electrode interface.
  • the operation of the new system is quite simple and is as follows.
  • the output signal from the TD transmitter 10 is applied transdermally and in peak LC series resonance to the head of the subject through the dielectric covered electrode 14 and the oppositely placed bare electrode 15 in the manner described hereinabove.
  • the acoustic signal is applied to the head of the subject in phase with the transdennal signal through the acoustic earphone 25 or, if desired, through another appropriate suitable acoustic transducer such as a conventional bone conductor.
  • the acoustic transducer is placed on the same side of the head as the dielectric covered electrode of the transdermal electrode pair 14, 15. in this manner, through a mechanism not yet completely understood, there appears to be some synergistic effect between the dielectric covered electrode 14 and the acoustic transducer 25.
  • the dual AF and RF signals then provide the subject with a vastly enhanced sensation of hearing in comparison to the hearing improvement that has heretofore been available with either of a transdermal type signal stimulation or an acoustic type signal stimulation.
  • the principles of the present invention may be used to adapt existing, conventional acoustic hearing aids in the following manner, without otherwise altering a conventional hearing aid, i.e., one comprising a microphone, amplifier, and earphone. It is necessary only to attach one side of the conventional coil 18 of the hearing aid earphone 25 to the head via conductor 19 and bare electrode 19 while conducting the other side of the conventional hearing aid speaker coil 18 to the same side of the head through an insulated electrode 14 appropriately directly connected to the other side of the speaker coil 18. Additionally, an adjustable resistance of from 0 to kilohms and a diode of the type IN 34 are placed in series with the speaker coil 18, as shown in FIG. 1.
  • a conventional acoustic-type hearing aid may contribute to improved hearing performance by its further combination with a transdermal system comprising the transmitter 10, the inductors l2 and 13 and the capacitive coupling electrode 15 and the capacitive coupling dielectric covered electrode 14, in the manner generally shown in FIG. 1.
  • This modified system will ordinarily employ only the microphone 11 of the transdermal system and will dispense with the microphone of the hearing aid (not shown).
  • the RF transdermal signal and the AF acoustic signal are independently delivered in synchronism to the head H of the listener through the electrodes 14, 15 and the earphone 25, respectively. It should be understood, however, that the diode and the resistor 21 illustrated in FIG.
  • FIG. 3 A circuit arrangement of a transdermal transmitter 10 having a balanced output and automatic carrier frequency control" is illustrated in FIG. 3.
  • the output of the TD signal generator of FIG. 3 is applied to the head of the subject through inductors 12, 13 and a pair of electrodes 14, 15, one of which is bare and one of which is dielectrically covered.
  • inductors 12, 13 and a pair of electrodes 14, 15, one of which is bare and one of which is dielectrically covered.
  • two bare electrodes which are applied to contralateral stylomastoid sides of the head.
  • the circuit of FIG. 3 comprises five transistors 151-155, respectively; 21 resistors, reference numerals 161-181, respectively; nine capacitors, 141-149, respectively; and one transformer 191, appropriately interconnected by conductors in the manner shown in FIG. 3.
  • the transistors 151, 156, and 157 cooperate to form a constant current differential amplifier which feeds the emitter followers of the transistors 153 and 154.
  • These transistors 153 and 154 in turn feed a series resonant circuit, which includes the inductors 12 and 13 and the human head, itself, which is, of course, disposed therebetween, as shown. In this manner, the head of the subject functions as a capacitor, as should be understood.
  • the current within the circuit peaks and the voltage drop across the resistor 164 becomes maximized.
  • This maximum voltage across the resistor 164 is in turn fed to the base of the transistor amplifier 152 and through a modulation network comprised of diodes 92 and 93 and fed back to the input of the differential amplifier. Therefore, the transistors 152, 153, 154, 155, and 156, in accordance with the principles of the invention, form an oscillator circuit, the frequency of which is determined by the inductors 12 and 13, and instantaneous capacitance of the head H.
  • the resistor 174 provides a level adjustment.
  • the audio signal is introduced into the circuit of FIG. 3 through the microphone 11 and is fed from a conventional hearing aid amplifier 100 to the base of the emitter follower 151, which drives the abovedescribed modulation transformer 191.
  • the resistors and 181 prevent the appearance of DC on the coil side of the capacitors 47 and 48.
  • circuit of FIG. 3 is currently preferred for operating the system of the present invention, it should be understood that any appropriate transmitting circuit which is adapted to deliver an amplitude modulated carrier signal in the range of approximately 18 to 36 kHz. to the head of a subject in LC series resonance will be acceptable for the purposes of the present invention. Accordingly, the circuit of FIG. 3 should be taken as illustrative of the principles of the invention and not limiting thereof.
  • a method for enhancing speech discrimination by a human subject of an AF signal comprising the steps of a. amplifying said AF signal and introducing said amplified signal to a region immediately adjacent the ear canal" of said subject,
  • the applications of said amplified AF signal and of said transdermal signal being synchronous.
  • transdermal signal is applied to the head at peak LC in series resonance at the carrier frequency.
  • transdermal signal is applied through a pair of electrodes one of which is bare and the other of which is insulated,
  • said bare electrode is placed on a first side of the head and said AF signal is applied to the opposite side of the head.
  • Apparatus for enhancing speech discrimination in a hard of hearing subject comprising a. means for amplifying an AF signal and introducing said amplified signal to a region immediately adjacent the ear canal of said subject,
  • c. means for balancedly applying said transdermal signal to the facial nerve system of the subject at opposite sides of the head at predetermined sites of the periaural and stylomastoid regions thereof,
  • the apparatus of claim 5, further includes a. a pair of inductor means through which said transdermal signal may be applied to the head of the subject.
  • said means for balancedly applying said transdermal signal to the facial nerve system of the subject at opposite sides of the head at predetermined sites of the periaural and stylomastoid regions thereof includes a pair of electrodes, one of which is bare and the other of which is insulated.
  • means for amplifying said AF signal and introducing said amplified signal to a region immediately adjacent the ear canal of said subject, and said means for balancedly applying said transdermal signal to the facial nerve system of the subject at opposite sides of the head at predetermined sites of the periaural and stylomastoid regions thereof are housed within a frame means.
  • the apparatus of claim 9 i riwhich b. a second layer comprising a thin self-supporting film of a.
  • said frame means includes an eyeglass frame and temples, insulating material superimposed on said layer of conducb. said means for balancedly applying said transdermal giv m-ml,
  • a third layer comprising a laminate of insulating film consides of the head at predetermined sites of the penaural ducfive fofldmulafing film superimposed on said sews? and stylomastold regions thereof includes a pair of elecporting film and adapted to Contact the skin of said trodes mounted on mner surfaces of said temples.
  • ject, and The aPparams of clam m wh'ch sald Insulated elec d. means maintaining said layers in unbonded surface controde comprises th a. a first layer comprising a layer of conductive material l0 mm one am) adapted to be directly connected to said signal source,

Abstract

The present invention relates to the stimulation of the sensation of hearing in persons of impaired hearing abilities or in certain cases in persons totally deaf utilizing RF energy. More particularly, the present invention relates to a method and apparatus for imparting synchronous AF or ''''acoustic'''' signals and so-called ''''transdermal'''' or RF signals. Hearing and improved speech discrimination, in accordance with one aspect of the present invention, is stimulated by the application of an AF acoustical signal to the ''''ear system'''' conventional biomechanism of hearing, which is delivered to the brain through the ''''normal'''' channels of hearing and a separate transdermal RF electrical signal which is applied to the ''''facial nerve system'''' and is detectable as a sensation of hearing. Vastly improved and enhanced hearing may be achieved by imparting an AF acoustic signal to the ear system by means of ''''conventional'''' transducers, such as electroacoustic speakers of ''''in the ear'''' hearing aids; piezoelectric or mechanical transducers of conventional ''''bone conduction''''-type hearing aids; and so-called ''''intraoral bone conduction transducers'''' of the type employed in the hearing system disclosed in Puharich and Lawrence U.S. Pat. No. 2,995,633 and No. 3,170,993 and No. 3,156,787, and by simultaneously applying a transdermal signal, which signal is an RF carrier signal amplitude modulated with AF information across the head of the subject, the head acting as capacitance in LC series resonance of the RF carrier frequency. Importantly, the applied balanced transdermal signal is in the form of a substantially pure sine wave, and it is applied to the head through one bare and one insulated electrode. The applied transdermal signal is applied to the periaural and stylomastoid regions of the head and, accordingly, the apparatus of the invention may be readily adapted for use in the temples of ''''eyeglass'''' hearing aid devices.

Description

United States Patent [72] Inventors Henry K. Puharich Ossining; Joseph L. Lawrence, New York, both of N.Y.
[21] Appl. No. 1,334
[22] Filed Jan. 8, 1970 [45] Patented Dec. 21,1971
[73] Assignee lntelectron Corporation New York, N.Y. Continuation-impart of application Ser. No. 682,152, Nov. 13, 1967, now Patent No. 3,497,637, and a continuation-in-part of 446,267, Apr. 6, 1965, now abandoned. This application ,Ian. 8, 1970, Ser. No. 1,334
[54] HEARING SYSTEMS l 1 Claims, 3 Drawing Figs.
[52] U.S.Cl 179/1071! [51] ll04r 25/00 107 BC, 107 E, 107 H, 107 S; 128/15 Primary Examiner Kathleen H. Claffy Assistant ExaminerThomas L. Kundert Attorney-Mandeville and Schweitzer ABSTRACT: The present invention relates to the stimulation of the sensation of hearing in persons of impaired hearing abilities or in certain cases in persons totally deaf utilizing RF the facial nerve system" and is detectable as a sensation of hearing. Vastly improved and enhanced hearing may be achieved by imparting an AF acoustic signal to the ear system by means of conventional" transducers, such as electroacoustic speakers of in the ear" hearing aids; piezoelectric or mechanical transducers of conventional bone conduction"-type hearing aids; and so-called intraoral bone conduction transducers" of the type employed in the hearing system disclosed in Puharich and Lawrence US. Pat. No. 2,995,633 and No. 3,170,993 and No. 3,156,787, and by simultaneously applying a transdermal signal, which signal is an RF carrier signal amplitude modulated with AF information across the head of the subject, the head acting as capacitance in LC series resonance of the RF carrier frequency. importantly, the applied balanced transdermal signal is in the form of a substantially pure sine wave, and it is applied to the head through one bare and one insulated electrode. The applied transdermal signal is applied to the periaural and stylomastoid regions of the head and, accordingly, the apparatus of the invention may be readily adapted for use in the temples of yes fh nsa ddsvi s BALANCED OUTPUT AFC TD SYSTEM PATENlfiunzcz! zen I 31629521 SHEET 1 BF 2 BALANCED OUTPUT AFC TD SYSTEM INVENTORS HENRY K. PUHARICH JOSEPH 1.. LAWRENCE ATTORNEYS PATENTEU HECZI I971 $629,521
SHEET 2 OF 2 FIG. 3
INVENTORS HENRY K. PUHARICH JOSEPH L. LAWRENCE ATTORNEYS HEARING SYSTEMS RELATION TO COPENDING APPLICATIONS This application is a continuation-in-part of our copending 5 SUMMARY OF THE INVENTION Heretofore, several systems employing so-called dual stimulation" have been proposed for use in the aiding of the hearing of persons who are partially deaf. Some of these systems have employed dual modes of acoustical stimulation; for example, a conventional air-conducted acoustical signal may be delivered to the ear canal through an earphone type of speaker while a separate bone-conducted acoustic signal is delivered to the same normal channels of hearing, i.e., ear system or conventional hearing biomechanism, through an appropriately situated bone conductor. It has also been broadly proposed heretofore to combine acoustic hearing with electrically stimulated hearing to aid deaf or partially deaf persons. The present invention is directed to a specific improvement in the latter type of dual stimulation hearing systems and provides a significant improvement in hearing and speech discrimination over what has heretofore been obtainable in the art.
Specifically, the vastly improved results of the method and apparatus of the new invention are obtained by the employment of a new and improved transdermal transmitting system; the employment of new and improved transdermal transducer means for. coupling the transdermal signal to the subject; and the employment of specific circuit parameters to achieve maximum improvement in hearing.
More specifically, the apparatus of the present invention delivers an acoustic signal to an earphone or bone conductor type transducer and simultaneously delivers a transdermal signal to the head of the user at contralateral, periaural, and/or stylomastoid regions of the head. The applied transdermal signal is a narrow width, amplitude modulated carrier signal, which carrier is usually in the range of 18 to 36 kHz. and which carrier is generated and coupled to the head of the subject in a manner whereby the transdermal signal is constantly driven across the head at peak LC series resonance of the carrier frequency. Appropriate circuitry is provided in order to maintain the transdermally applied signal at the peak LC series resonance despite changes in the capacitance of the coupling of the transdermal signal to the head of the subject which may be occasioned by physiological changes in the subject.
importantly and in accordance with an important principle of the present invention, improved speech discrimination is achieved by applying the transdermal signal to the head in the form of a substantially pure sine wave. Heretofore, applied sine waves have tended to be distorted by the head. However, in accordance with the invention, when the signal is applied to the stylomastoid regions of the head through one bare transdermal electrode and one insulated transdermal electrode placed contralaterally of the head, distortion of the sine wave is effectively eliminated.
In the case of totally deaf subjects who cannot hear" any acoustic signals whatever through the conventional hearing biomechanism, i.e., the ear system," the use of two bare electrodes has enabled the totally deaf to perceive sounds transmitted to the brain transdermally" through the single stimulus of a transdermal, amplitude modulated RF signal, coupled in peak LC series resonance of the carrier frequency.
For a more complete understanding of the present invention and a better appreciation of its attendant advantages, reference should be made to the following detailed description taken in conjunction with the accompanying drawings.
DESCRIPTION OF DRAWINGS FIG. 1 is a schematic view of a dual stimulus hearing system,
' mounted in an eyeglass frame and embodying the principles of the present invention;
FIG. 2 is an enlarged, cross-sectional view of an improved transdermal electrode means for use in coupling transdermal signals to a subject for the practice of the present invention;
FIG. 3 is a preferred circuit arrangement for transdermal signal generating apparatus of the present invention.
DETAILED DESCRIPTION OF THE PRESENT INVENTION Referring now to FIG. 1, audio information is introduced through microphone 11 to a transdermal signal generator 10, of the type disclosed in copending applications Ser. No. 633,035, now U.S. Pat. No. 3,563,246; Ser. No. 682,152; now U.S. Pat. No. 3,497,637; and Ser. No. 446,267, now abandoned. The output of signal generator 10 is applied both acousticallyand transdermally to the head H of a subject 4 in the following manner and in accordance with the principles of the present invention.
The transdermal (TD) signal, an amplitude modulated balanced RF signal, is coupled to the contralateral stylomastoid regions of the head through two separate inductors l2 and 13, a dielectric covered electrode 14, and a bare metal electrode 15, which electrodes are mounted on the inner surfaces of eyeglass temples T, as shown in FIG. 1. That is to say, the TD signal levels are balanced on each side of the head for optimum speech discrimination in accordance with the invention. The dielectric covered electrode 14, which is shown in greater detail in FIG. 2 and described more specifically hereinafter, is placed on the same side of the head as the magnetic speaker 25 or other conventional transducer such as a bone conductor, which imparts an amplified acoustic signal directly into the ear system of the subject. The bare electrode 15 is always placed on the opposite side of the head from the speaker 25 and the dielectric covered electrode 14, in accordance with a specific aspect of the present invention and in order to minimize distortion of the pure sine wave type of transdermal signal applied to the head. As shown in FIG. 1, electrodes 14 and 15 are connected to the output of the TD transmitter 10 by conductors l5 and 14, respectively.
The transdermal (TD) signal generator 10 may advantageously incorporate certain of the features described in a copending application, Ser. No. 633,035, filed Apr. 24, 1967, now U.S. Pat. No. 3,563,246, by Henry K. Puharich and Joseph L. Lawrence and also certain features described in an earlier application, Ser. No. 446,267, filed Apr. 6, 1965, now abandoned, by the same inventors. Reference to these applications may be made for further details.
More specifically and with reference to FIG. 1, the output of the transdermal signal generator 10 includes the pair of electrodes 14, 15, one of which is covered with a dielectric material (14) and the other of which is bare (15), although in certain applications (e.g. for totally deaf persons) both may be bare. In series with the electrodes 14, 15 are large inductances 12, 13, advantageously in the range of 2 to 30 millihenries and adjustable within that range for the accommodation of different subjects. The TD signal generating circuitry of the transmitter 10, once energized and periodically pulsed, will oscillate at a frequency, herein referred to as the carrier frequency, which is substantially in a circuit resonant relation with the body of the subject, for maximum effectiveness of the power input, as described in more detail in the above-mentioned copending applications.
Desirably and as an important aspect of the invention, the
inductances l2, 13 are selected, with respect to a given sub ject, to provide a carrier signal at a frequency on the order of about 18 to about 36 kHz. By designing and constructing the circuit for the TD transmitter so that the inductances l2, 13 are the primary determinants of resonant frequency, in relation to the capacitance of the coupled electrodes 14, 15, the resonant frequency may be kept constant notwithstanding momentary changes in circuit capacitance due to physiological and other changes in the body of the subject.
In accordance with the principles of the present invention, an in-phase acoustic or AF signal is simultaneously applied to the head of the subject through a conventional transducer such as an electromagnetic speaker of an earphone 25. The acoustic signal is derived from the transdermal transmitter 10 and is applied to the coil 18 of the magnetic speaker 25 by connecting one side of the coil 18 to the conductor 14' by conductor 18', while the other side of the coil 18 is connected to a conductor 19' which is connected to an auxiliary bare metal electrode 19, which is placed against the side of the head (above the ear) opposite the site of the bare transdermal electrode 15. In accordance with the principles of the invention, two separate circuits will be completed through the head, a transdermal circuit between the electrodes 14 and and the acoustic circuit in which one side of the coil 18 is connected directly to the TD transmitter while the other side of the coil 18 is connected through the head to the other side of the TD transmitter 10.
in accordance with the principles of the invention, vastly improved hearing and speech discrimination may be obtained by a person having impaired hearing when the stem of FIG. 1 is operated in the following manner. A desired audio input in the form of an audio (AF) signal may be delivered to the transdermal transmitter system 10 through an input microphone 11 and the RF output of the transmitter will then be transmitted to the head of the subject applied thereto in the form of synchronous transdermal (RF) signals and acoustic (AF) signals, the combined effect of which, on hearing, will be significantly better than if either type of signal stimulation had been used independently. That is to say, using a conventional acoustic type earphone hearing aid, the subject's hearing and speech discrimination abilities typically will be enhanced (over completely unaided hearing) approximately 50 percent; the same may be said for the use of a transdermal type hearing aid by itself. However, when both AF and RF stimulations are used simultaneously and in accordance with the inventive principles, hearing abilities and speech discrimination have been enhanced (over completely unaided hearing) as much as 75 percent. Therefore, there is a definite increase in hearing (in terms of PB speech discrimination) over and beyond what has heretofore been available by the use of either pure acoustic stimulation or pure transdermal stimulation, which is attributed to synergistic effects of the combination of AF and RF signals in the manner described.
More specifically and by way of example, a sample group comprised of 12 hard of hearing patients was measured in a first or control testing" with standard audiometry techniques, and it was found that the average speech discrimination ability of the group was 26.2 percent as measured with phonetically balanced words, or the PB test." This measurement represented a control" or standard for comparison. Thereafter, the 12 patients took several weeks of TD therapy in accordance with the principles and inventions set forth in detail in our copending application, Ser. No. 633,035, filed Apr. 24, 1967, for Electrotherapy System." When measured in a second testing" with the same type of acoustic earphone PB test as used in establishing the control level, the average PB speech discrimination score of the group showed 43.0 percent or an increment of 16.8 percent. Following the second testing, the group of patients was tested in a third or TD testing with the TD signal rather than the acoustic signal, as the speech signal source, and the average PB speech discrimination of the group was 54 percent, an increment of 27.8 percent. Following the second and third testing, the group was tested with the signal source of the invention which combined the earphone signals of the second testing and the TD signal of the third tesu'ng, which signals were synchronously applied in accordance with the invention. Remarkably, the average PB speech discrimination score of the group was raised to 73.8 percent, an improvement of 47.6 percent.
In accordance with one more specific aspect of the present invention, the dielectric covered electrode 14 may have the following configuration which has been found to couple, in a highly efficient manner, transdermal signals to the head of the subject. The electrode 14 comprises three layers, a fine wire mesh conductor 52; a 0.25 mil Mylar film 54 superimposed on the mesh; and a heat bonded laminate 56 of 0.25 mil Mylarl-mil aluminum foil-0.25 mil Mylar superimposed on the layer 54. The layers 52, 54, 56 loosely contact one another but are substantially unbonded throughout their interfaces. Furthermore, the integrity of the electrode 14 may be preserved mechanically by uniting the peripheral portions of the layers with cement or using a plastic housing disc 58 to hold the layers in the aforementioned contacting, but unbonded, relation. The disc electrode 14 may be used to advantage in any transdermal system such as those transdermal hearing and therapeutic systems illustrated and described in the aforementioned copending applications and may be formed as an integral part of an eyeglass hearing aid.
in the illustrated configuration of the electrode 14, the unbonded laminar construction provides highly effecu've transdermal energy transfer (i.e., more power and less distortion) from a signal source to the nervous system. It is theorized that the wire mesh conductor layers of the electrodes tend to maximize the nonuniform distribution of energy of the TD signal, while the loose or floating intermediate Mylar film layers tend to provide infinite capacitive adjustments as the layer flaps freely relative to the conductor. Furthermore, it is believed that the laminated layer which contacts the skin of the subject tends to smooth out nonuniforrnities of energy concentration which exist in the other two layers. That is to say, the foil conducts laterally of the direction of energy transfer, thus counteracting and preventing undue energy concentrations at the skin-electrode interface.
The importance of the multiple layers and the significance of their loose or unbonded relationship may be demonstrated by a comparison to a similar, but bonded, structure. Were the electrode layers to be bonded at their interfaces, energy transfer would occur, however, hearing improvement and minimization of distortion would be significantly less than that for the unbonded arrangement. Likewise, while an electrode configuration having only two layers, a conductor layer and a Mylar layer, would, in fact, transfer transdermal energy, the efiiciency of the transfer is significantly less than when the third layer of a Mylar-aluminum-Mylar laminate is employed.
The operation of the new system is quite simple and is as follows. The output signal from the TD transmitter 10 is applied transdermally and in peak LC series resonance to the head of the subject through the dielectric covered electrode 14 and the oppositely placed bare electrode 15 in the manner described hereinabove. The acoustic signal is applied to the head of the subject in phase with the transdennal signal through the acoustic earphone 25 or, if desired, through another appropriate suitable acoustic transducer such as a conventional bone conductor. Regardless of the choice of acoustic transducer (it being understood that it is possible in some instances to employ an intraoral, bone conductor type transducer), the acoustic transducer is placed on the same side of the head as the dielectric covered electrode of the transdermal electrode pair 14, 15. in this manner, through a mechanism not yet completely understood, there appears to be some synergistic effect between the dielectric covered electrode 14 and the acoustic transducer 25. The dual AF and RF signals then provide the subject with a vastly enhanced sensation of hearing in comparison to the hearing improvement that has heretofore been available with either of a transdermal type signal stimulation or an acoustic type signal stimulation.
The principles of the present invention may be used to adapt existing, conventional acoustic hearing aids in the following manner, without otherwise altering a conventional hearing aid, i.e., one comprising a microphone, amplifier, and earphone. It is necessary only to attach one side of the conventional coil 18 of the hearing aid earphone 25 to the head via conductor 19 and bare electrode 19 while conducting the other side of the conventional hearing aid speaker coil 18 to the same side of the head through an insulated electrode 14 appropriately directly connected to the other side of the speaker coil 18. Additionally, an adjustable resistance of from 0 to kilohms and a diode of the type IN 34 are placed in series with the speaker coil 18, as shown in FIG. 1. With these two modifications, a conventional acoustic-type hearing aid may contribute to improved hearing performance by its further combination with a transdermal system comprising the transmitter 10, the inductors l2 and 13 and the capacitive coupling electrode 15 and the capacitive coupling dielectric covered electrode 14, in the manner generally shown in FIG. 1. This modified system will ordinarily employ only the microphone 11 of the transdermal system and will dispense with the microphone of the hearing aid (not shown). The RF transdermal signal and the AF acoustic signal are independently delivered in synchronism to the head H of the listener through the electrodes 14, 15 and the earphone 25, respectively. It should be understood, however, that the diode and the resistor 21 illustrated in FIG. 1 are necessary only when adapting a conventional hearing aid of synergistic boosting" by a separately provided transdermal stimulation system. When the combined stimulation hearing system is supplied as an original unit, such as shown in FIG. 3, the volume control arrangement, provided by the resistor 20 and the diode 21, is not necessary.
A circuit arrangement of a transdermal transmitter 10 having a balanced output and automatic carrier frequency control" is illustrated in FIG. 3. The output of the TD signal generator of FIG. 3 is applied to the head of the subject through inductors 12, 13 and a pair of electrodes 14, 15, one of which is bare and one of which is dielectrically covered. As mentioned hereinabove, in certain applications where stimulation of hearing in the totally deaf is desired through transdermal stimulation only, it is necessary to employ two bare electrodes which are applied to contralateral stylomastoid sides of the head.
The circuit of FIG. 3, comprises five transistors 151-155, respectively; 21 resistors, reference numerals 161-181, respectively; nine capacitors, 141-149, respectively; and one transformer 191, appropriately interconnected by conductors in the manner shown in FIG. 3. In this version of an automatic carrier frequency controlled transdermal transmitter, the transistors 151, 156, and 157 cooperate to form a constant current differential amplifier which feeds the emitter followers of the transistors 153 and 154. These transistors 153 and 154 in turn feed a series resonant circuit, which includes the inductors 12 and 13 and the human head, itself, which is, of course, disposed therebetween, as shown. In this manner, the head of the subject functions as a capacitor, as should be understood.
In accordance with the principles outlined hereinabove, at resonant frequency of this circuit, the current within the circuit peaks and the voltage drop across the resistor 164 becomes maximized. This maximum voltage across the resistor 164 is in turn fed to the base of the transistor amplifier 152 and through a modulation network comprised of diodes 92 and 93 and fed back to the input of the differential amplifier. Therefore, the transistors 152, 153, 154, 155, and 156, in accordance with the principles of the invention, form an oscillator circuit, the frequency of which is determined by the inductors 12 and 13, and instantaneous capacitance of the head H. In this circuit, the resistor 174 provides a level adjustment.
As shown and as will be appreciated, the audio signal is introduced into the circuit of FIG. 3 through the microphone 11 and is fed from a conventional hearing aid amplifier 100 to the base of the emitter follower 151, which drives the abovedescribed modulation transformer 191. The resistors and 181 prevent the appearance of DC on the coil side of the capacitors 47 and 48.
While the circuit of FIG. 3 is currently preferred for operating the system of the present invention, it should be understood that any appropriate transmitting circuit which is adapted to deliver an amplitude modulated carrier signal in the range of approximately 18 to 36 kHz. to the head of a subject in LC series resonance will be acceptable for the purposes of the present invention. Accordingly, the circuit of FIG. 3 should be taken as illustrative of the principles of the invention and not limiting thereof.
We claim:
1. A method for enhancing speech discrimination by a human subject of an AF signal comprising the steps of a. amplifying said AF signal and introducing said amplified signal to a region immediately adjacent the ear canal" of said subject,
modulating an RF carrier signal with said AF signal to produce a transdermal signal,
balancedly applying said predetermined sites of transdermal signal to the facial nerve system of the subject at opposite sides of the head at the periaural and stylomastoid regions thereof,
. the applications of said amplified AF signal and of said transdermal signal being synchronous.
The method of claim 1, further characterized in that said TD signal is applied to each side of the head through an inductor.
The method of claim 2, further characterized in that said transdermal signal is applied to the head at peak LC in series resonance at the carrier frequency.
The method of claim 1, further characterized in that said transdermal signal is applied through a pair of electrodes one of which is bare and the other of which is insulated,
said bare electrode is placed on a first side of the head and said AF signal is applied to the opposite side of the head.
5. Apparatus for enhancing speech discrimination in a hard of hearing subject, comprising a. means for amplifying an AF signal and introducing said amplified signal to a region immediately adjacent the ear canal of said subject,
b. means for modulating an RF carrier signal with said AF signal to produce a transdermal signal,
c. means for balancedly applying said transdermal signal to the facial nerve system of the subject at opposite sides of the head at predetermined sites of the periaural and stylomastoid regions thereof,
d. the applications of said amplified AF signal and of said transdermal signal being synchronous.
6. The apparatus of claim 5, further includes a. a pair of inductor means through which said transdermal signal may be applied to the head of the subject.
7. The apparatus of claim 5, further characterized in that a. said transdermal signal is applied to the head at peak LC series resonance at the carrier frequency.
8. The apparatus of claim 5, which is further characterized in that a. said means for balancedly applying said transdermal signal to the facial nerve system of the subject at opposite sides of the head at predetermined sites of the periaural and stylomastoid regions thereof includes a pair of electrodes, one of which is bare and the other of which is insulated. The apparatus of claim 5, further characterized in that means for amplifying said AF signal and introducing said amplified signal to a region immediately adjacent the ear canal of said subject, and said means for balancedly applying said transdermal signal to the facial nerve system of the subject at opposite sides of the head at predetermined sites of the periaural and stylomastoid regions thereof are housed within a frame means.
7 8 10. The apparatus of claim 9: i riwhich b. a second layer comprising a thin self-supporting film of a. said frame means includes an eyeglass frame and temples, insulating material superimposed on said layer of conducb. said means for balancedly applying said transdermal giv m-ml,
8 to thfi facial nerve 'f of subjec at FP c. a third layer comprising a laminate of insulating film consides of the head at predetermined sites of the penaural ducfive fofldmulafing film superimposed on said sews? and stylomastold regions thereof includes a pair of elecporting film and adapted to Contact the skin of said trodes mounted on mner surfaces of said temples. ject, and The aPparams of clam m wh'ch sald Insulated elec d. means maintaining said layers in unbonded surface controde comprises th a. a first layer comprising a layer of conductive material l0 mm one am) adapted to be directly connected to said signal source,

Claims (11)

1. A method for enhancing speech discrimination by a human subject of an AF signal comprising the steps of a. amplifying said AF signal and introducing said amplified signal to a region immediately adjacent the ''''ear canal'''' of said subject, b. modulating an RF carrier signal with said AF signal to produce a transdermal signal, c. balancedly applying said predetermined sites of transdermal signal to the facial nerve system of the subject at opposite sides of the head at the periaural and stylomastoid regions thereof, d. the applications of said amplified AF signal and of said transdermal signal being synchronous.
2. The method of claim 1, further characterized in that a. said TD signal is applied to each side of the head through an inductor.
3. The method of claim 2, further characterized in that a. said transdermal signal is applied to the head at peak LC in series resonance at the carrier frequency.
4. The method of claim 1, further characterized in that a. said transdermal signal is applied through a pair of electrodes one of which is bare and the other of which is insulated, b. said bare electrode is placed on a first side of the head and said AF signal is applied to the opposite side of the head.
5. Apparatus for enhancing speech discrimination in a hard of hearing subject, comprising a. means for amplifying an AF signal and introducing said amplified signal to a region immediately adjacent the ''''ear canal'''' of said subject, b. means for modulating an RF carrier signal with said AF signal to produce a transdermal signal, c. means for balancedly applying said transdermal signal to the facial nerve system of the subject at opposite sides of the head at predetermined sites of the periaural and stylomastoid regions thereof, d. the applications of said amplified AF signal and of said transdermal signal being synchronous.
6. The apparatus of claim 5, further includes a. a pair of inductor means through which said transdermal signal may be applied to the head of the subject.
7. The apparatus of claim 5, further characterized in that a. said transdermal signal is applied to the head at peak LC series resonance at the carrier frequency.
8. The apparatus of claim 5, which is further characterized in that a. said means for balancedly applying said transdermal signal to the facial nerve system of the subject at opposite sides of the head at predetermined sites of the periaural and stylomastoid regions thereof includes a pair of electrodes, one of which is bare and the other of which is insulated.
9. The apparatus of claim 5, further characterized in that a. means for amplifying said AF signal and introducing said amplified signal to a region immediately adjacent the ''''ear canal'''' of said subject, and said means for balancedly applying said transdermal signal to the facial nerve system of the subject at opposite sides of the head at predetermined sites of the periaural and stylomastoid regions thereof are housed within a frame means.
10. The apparatus of claim 9, in which a. said frame means includes an eyeglass frame and temples, b. said means for balancedly applying said transdermal signal to the facial nerve system of the subject at opposite sides of the head at predetermined sites of the periaural and stylomastoid regions thereof includes a pair of electrodes mounted on inNer surfaces of said temples.
11. The apparatus of claim 8, in which said insulated electrode comprises a. a first layer comprising a layer of conductive material adapted to be directly connected to said signal source, b. a second layer comprising a thin self-supporting film of insulating material superimposed on said layer of conductive material, c. a third layer comprising a laminate of insulating film conductive foil-insulating film superimposed on said self-supporting film and adapted to contact the skin of said subject, and d. means maintaining said layers in unbonded surface contact with one another.
US1334A 1970-01-08 1970-01-08 Hearing systems Expired - Lifetime US3629521A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US133470A 1970-01-08 1970-01-08

Publications (1)

Publication Number Publication Date
US3629521A true US3629521A (en) 1971-12-21

Family

ID=21695507

Family Applications (1)

Application Number Title Priority Date Filing Date
US1334A Expired - Lifetime US3629521A (en) 1970-01-08 1970-01-08 Hearing systems

Country Status (1)

Country Link
US (1) US3629521A (en)

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766331A (en) * 1971-11-24 1973-10-16 Zcm Ltd Hearing aid for producing sensations in the brain
US4368459A (en) * 1980-12-16 1983-01-11 Robert Sapora Educational apparatus and method for control of deaf individuals in a mixed teaching environment
US4629834A (en) * 1984-10-31 1986-12-16 Bio-Dynamics Research & Development Corporation Apparatus and method for vibratory signal detection
US4628907A (en) * 1984-03-22 1986-12-16 Epley John M Direct contact hearing aid apparatus
US4821323A (en) * 1988-02-19 1989-04-11 Papiernik Raymond S Stereo headphone
US4877027A (en) * 1988-06-06 1989-10-31 Brunkan Wayne B Hearing system
US4982434A (en) * 1989-05-30 1991-01-01 Center For Innovative Technology Supersonic bone conduction hearing aid and method
WO1992009251A1 (en) * 1990-11-28 1992-06-11 Canadian Bionic Research, Inc. Communication device for transmitting audio information to a user
US5182774A (en) * 1990-07-20 1993-01-26 Telex Communications, Inc. Noise cancellation headset
EP0555278A1 (en) * 1990-11-01 1993-08-18 Cochlear Pty. Ltd. Bimodal speech processor
WO1996000051A1 (en) * 1994-06-23 1996-01-04 Hearing Innovations Incorporated Tinnitus masking using ultrasonic signals
US5511132A (en) * 1992-08-31 1996-04-23 Pioneer Electronic Corporation Communication device having air-borne and solid-borne transmitting and receiving devices
US5591156A (en) * 1992-11-18 1997-01-07 Chikuma; Toichi Semiconductor medical treatment instrument
WO2000007658A1 (en) * 1998-08-06 2000-02-17 Shmuel Peltz Method and appliances for electrostimulation
US6118882A (en) * 1995-01-25 2000-09-12 Haynes; Philip Ashley Communication method
US6217508B1 (en) 1998-08-14 2001-04-17 Symphonix Devices, Inc. Ultrasonic hearing system
US6470214B1 (en) * 1996-12-13 2002-10-22 The United States Of America As Represented By The Secretary Of The Air Force Method and device for implementing the radio frequency hearing effect
US6731769B1 (en) * 1998-10-14 2004-05-04 Sound Techniques Systems Llc Upper audio range hearing apparatus and method
US7181032B2 (en) * 2001-03-13 2007-02-20 Phonak Ag Method for establishing a detachable mechanical and/or electrical connection
US20070195978A1 (en) * 2006-02-17 2007-08-23 Zounds, Inc. Method for communicating with a hearing aid
US20100314921A1 (en) * 2008-02-20 2010-12-16 Electronics And Telecommunications Research Institute Chair and multimedia player comprising sound transmission apparatus performing human-body communications
US20110270361A1 (en) * 2010-05-02 2011-11-03 Lake Biosciences, Llc Modulating function of the facial nerve system or related neural structures via the ear
US20130142363A1 (en) * 2011-12-01 2013-06-06 At&T Intellectual Property I, L.P. Devices and methods for transferring data through a human body
US20130245727A1 (en) * 2012-03-16 2013-09-19 Cutera, Inc. Systems and methods for thermolipolysis using rf energy
US9272157B2 (en) 2010-05-02 2016-03-01 Nervive, Inc. Modulating function of neural structures near the ear
US9349280B2 (en) 2013-11-18 2016-05-24 At&T Intellectual Property I, L.P. Disrupting bone conduction signals
US9405892B2 (en) 2013-11-26 2016-08-02 At&T Intellectual Property I, L.P. Preventing spoofing attacks for bone conduction applications
US9430043B1 (en) 2000-07-06 2016-08-30 At&T Intellectual Property Ii, L.P. Bioacoustic control system, method and apparatus
US9582071B2 (en) 2014-09-10 2017-02-28 At&T Intellectual Property I, L.P. Device hold determination using bone conduction
US9589482B2 (en) 2014-09-10 2017-03-07 At&T Intellectual Property I, L.P. Bone conduction tags
US9594433B2 (en) 2013-11-05 2017-03-14 At&T Intellectual Property I, L.P. Gesture-based controls via bone conduction
US9600079B2 (en) 2014-10-15 2017-03-21 At&T Intellectual Property I, L.P. Surface determination via bone conduction
US9715774B2 (en) 2013-11-19 2017-07-25 At&T Intellectual Property I, L.P. Authenticating a user on behalf of another user based upon a unique body signature determined through bone conduction signals
US9882992B2 (en) 2014-09-10 2018-01-30 At&T Intellectual Property I, L.P. Data session handoff using bone conduction
US10045732B2 (en) 2014-09-10 2018-08-14 At&T Intellectual Property I, L.P. Measuring muscle exertion using bone conduction
US10065047B2 (en) 2013-05-20 2018-09-04 Nervive, Inc. Coordinating emergency treatment of cardiac dysfunction and non-cardiac neural dysfunction
US10108984B2 (en) 2013-10-29 2018-10-23 At&T Intellectual Property I, L.P. Detecting body language via bone conduction
US10678322B2 (en) 2013-11-18 2020-06-09 At&T Intellectual Property I, L.P. Pressure sensing via bone conduction
US10831316B2 (en) 2018-07-26 2020-11-10 At&T Intellectual Property I, L.P. Surface interface

Cited By (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766331A (en) * 1971-11-24 1973-10-16 Zcm Ltd Hearing aid for producing sensations in the brain
US4368459A (en) * 1980-12-16 1983-01-11 Robert Sapora Educational apparatus and method for control of deaf individuals in a mixed teaching environment
US4628907A (en) * 1984-03-22 1986-12-16 Epley John M Direct contact hearing aid apparatus
US4629834A (en) * 1984-10-31 1986-12-16 Bio-Dynamics Research & Development Corporation Apparatus and method for vibratory signal detection
US4821323A (en) * 1988-02-19 1989-04-11 Papiernik Raymond S Stereo headphone
US4877027A (en) * 1988-06-06 1989-10-31 Brunkan Wayne B Hearing system
US4982434A (en) * 1989-05-30 1991-01-01 Center For Innovative Technology Supersonic bone conduction hearing aid and method
WO1992012605A1 (en) * 1989-05-30 1992-07-23 Center For Innovative Technology Supersonic bone conduction hearing aid and method
US5182774A (en) * 1990-07-20 1993-01-26 Telex Communications, Inc. Noise cancellation headset
EP0555278A1 (en) * 1990-11-01 1993-08-18 Cochlear Pty. Ltd. Bimodal speech processor
EP0555278A4 (en) * 1990-11-01 1994-08-10 Cochlear Pty Ltd Bimodal speech processor
US5337364A (en) * 1990-11-28 1994-08-09 Canadian Bionic Research Inc. Communication device for transmitting audio information to a user
WO1992009251A1 (en) * 1990-11-28 1992-06-11 Canadian Bionic Research, Inc. Communication device for transmitting audio information to a user
US5511132A (en) * 1992-08-31 1996-04-23 Pioneer Electronic Corporation Communication device having air-borne and solid-borne transmitting and receiving devices
US5591156A (en) * 1992-11-18 1997-01-07 Chikuma; Toichi Semiconductor medical treatment instrument
WO1996000051A1 (en) * 1994-06-23 1996-01-04 Hearing Innovations Incorporated Tinnitus masking using ultrasonic signals
US6377693B1 (en) * 1994-06-23 2002-04-23 Hearing Innovations Incorporated Tinnitus masking using ultrasonic signals
US6118882A (en) * 1995-01-25 2000-09-12 Haynes; Philip Ashley Communication method
US6470214B1 (en) * 1996-12-13 2002-10-22 The United States Of America As Represented By The Secretary Of The Air Force Method and device for implementing the radio frequency hearing effect
US6587729B2 (en) * 1996-12-13 2003-07-01 The United States Of America As Represented By The Secretary Of The Air Force Apparatus for audibly communicating speech using the radio frequency hearing effect
WO2000007658A1 (en) * 1998-08-06 2000-02-17 Shmuel Peltz Method and appliances for electrostimulation
US6217508B1 (en) 1998-08-14 2001-04-17 Symphonix Devices, Inc. Ultrasonic hearing system
US6731769B1 (en) * 1998-10-14 2004-05-04 Sound Techniques Systems Llc Upper audio range hearing apparatus and method
US10126828B2 (en) 2000-07-06 2018-11-13 At&T Intellectual Property Ii, L.P. Bioacoustic control system, method and apparatus
US9430043B1 (en) 2000-07-06 2016-08-30 At&T Intellectual Property Ii, L.P. Bioacoustic control system, method and apparatus
US7181032B2 (en) * 2001-03-13 2007-02-20 Phonak Ag Method for establishing a detachable mechanical and/or electrical connection
US20070195978A1 (en) * 2006-02-17 2007-08-23 Zounds, Inc. Method for communicating with a hearing aid
US8538050B2 (en) * 2006-02-17 2013-09-17 Zounds Hearing, Inc. Method for communicating with a hearing aid
US8684457B2 (en) * 2008-02-20 2014-04-01 Electronics And Telecommunications Research Institute Chair and multimedia player comprising sound transmission apparatus performing human body communications
US20100314921A1 (en) * 2008-02-20 2010-12-16 Electronics And Telecommunications Research Institute Chair and multimedia player comprising sound transmission apparatus performing human-body communications
US20110270361A1 (en) * 2010-05-02 2011-11-03 Lake Biosciences, Llc Modulating function of the facial nerve system or related neural structures via the ear
US10105549B2 (en) 2010-05-02 2018-10-23 Nervive, Inc. Modulating function of neural structures near the ear
US9272157B2 (en) 2010-05-02 2016-03-01 Nervive, Inc. Modulating function of neural structures near the ear
US9339645B2 (en) * 2010-05-02 2016-05-17 Nervive, Inc. Modulating function of the facial nerve system or related neural structures via the ear
US8908894B2 (en) * 2011-12-01 2014-12-09 At&T Intellectual Property I, L.P. Devices and methods for transferring data through a human body
US9712929B2 (en) 2011-12-01 2017-07-18 At&T Intellectual Property I, L.P. Devices and methods for transferring data through a human body
US20130142363A1 (en) * 2011-12-01 2013-06-06 At&T Intellectual Property I, L.P. Devices and methods for transferring data through a human body
US20130245727A1 (en) * 2012-03-16 2013-09-19 Cutera, Inc. Systems and methods for thermolipolysis using rf energy
US10065047B2 (en) 2013-05-20 2018-09-04 Nervive, Inc. Coordinating emergency treatment of cardiac dysfunction and non-cardiac neural dysfunction
US10108984B2 (en) 2013-10-29 2018-10-23 At&T Intellectual Property I, L.P. Detecting body language via bone conduction
US10281991B2 (en) 2013-11-05 2019-05-07 At&T Intellectual Property I, L.P. Gesture-based controls via bone conduction
US10831282B2 (en) 2013-11-05 2020-11-10 At&T Intellectual Property I, L.P. Gesture-based controls via bone conduction
US9594433B2 (en) 2013-11-05 2017-03-14 At&T Intellectual Property I, L.P. Gesture-based controls via bone conduction
US9349280B2 (en) 2013-11-18 2016-05-24 At&T Intellectual Property I, L.P. Disrupting bone conduction signals
US10964204B2 (en) 2013-11-18 2021-03-30 At&T Intellectual Property I, L.P. Disrupting bone conduction signals
US9997060B2 (en) 2013-11-18 2018-06-12 At&T Intellectual Property I, L.P. Disrupting bone conduction signals
US10678322B2 (en) 2013-11-18 2020-06-09 At&T Intellectual Property I, L.P. Pressure sensing via bone conduction
US10497253B2 (en) 2013-11-18 2019-12-03 At&T Intellectual Property I, L.P. Disrupting bone conduction signals
US9715774B2 (en) 2013-11-19 2017-07-25 At&T Intellectual Property I, L.P. Authenticating a user on behalf of another user based upon a unique body signature determined through bone conduction signals
US9972145B2 (en) 2013-11-19 2018-05-15 At&T Intellectual Property I, L.P. Authenticating a user on behalf of another user based upon a unique body signature determined through bone conduction signals
US9405892B2 (en) 2013-11-26 2016-08-02 At&T Intellectual Property I, L.P. Preventing spoofing attacks for bone conduction applications
US9736180B2 (en) 2013-11-26 2017-08-15 At&T Intellectual Property I, L.P. Preventing spoofing attacks for bone conduction applications
US9582071B2 (en) 2014-09-10 2017-02-28 At&T Intellectual Property I, L.P. Device hold determination using bone conduction
US10276003B2 (en) 2014-09-10 2019-04-30 At&T Intellectual Property I, L.P. Bone conduction tags
US9589482B2 (en) 2014-09-10 2017-03-07 At&T Intellectual Property I, L.P. Bone conduction tags
US10045732B2 (en) 2014-09-10 2018-08-14 At&T Intellectual Property I, L.P. Measuring muscle exertion using bone conduction
US9882992B2 (en) 2014-09-10 2018-01-30 At&T Intellectual Property I, L.P. Data session handoff using bone conduction
US11096622B2 (en) 2014-09-10 2021-08-24 At&T Intellectual Property I, L.P. Measuring muscle exertion using bone conduction
US9600079B2 (en) 2014-10-15 2017-03-21 At&T Intellectual Property I, L.P. Surface determination via bone conduction
US10831316B2 (en) 2018-07-26 2020-11-10 At&T Intellectual Property I, L.P. Surface interface

Similar Documents

Publication Publication Date Title
US3629521A (en) Hearing systems
US3752939A (en) Prosthetic device for the deaf
US3267931A (en) Electrically stimulated hearing with signal feedback
US3751605A (en) Method for inducing hearing
US8285384B2 (en) Implantable medical devices with multiple transducers
Jones et al. Three mechanisms of hearing by electrical stimulation
US4611598A (en) Multi-frequency transmission system for implanted hearing aids
US4354064A (en) Vibratory aid for presbycusis
US3170993A (en) Means for aiding hearing by electrical stimulation of the facial nerve system
US4764957A (en) Earpiece, telephone handset and headphone intended to correct individual hearing deficiencies
US3393279A (en) Nervous system excitation device
DK156120B (en) AUDITIVE STIMULATION SYSTEM
JPS61159967A (en) Method for transmitting sonic wave information to deaf person and audio nerve transmitting system for stimulating tactile sensation of deaf person
US20170171677A1 (en) Tinnitus treatment systems and methods
US4052572A (en) Hearing aid
US3586791A (en) Method and apparatus for hearing by biodetection and biotransduction of radiofrequency energy
Goode et al. Audition via electromagnetic induction
EP3842093A1 (en) Bone conduction apparatus having tens therapy function
US3497637A (en) Transducer for stimulation of facial nerve system with r-f energy
WO1988000847A1 (en) Cortical hearing aid
Jerger et al. Binaural hearing aids. An enigma
US3384090A (en) Method and apparatus for treatment of the deafness, caused by diseases of the middleand internal ear
JPH01244750A (en) Multiple channel apparatus for subcutaneous implantation
KR200282696Y1 (en) Bone conduction speaker of piezoelectric type
Kellaway The mechanism of the electrophonic effect

Legal Events

Date Code Title Description
AS Assignment

Owner name: BIOLECTRON, INC., 200 HOLT ST., HACKENSACK, NJ 076

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:CHEN, C.Y.;REEL/FRAME:004271/0859

Effective date: 19840530